Newsroom

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming March 23, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired BellRing Brands, Inc. ("BellRing " or the Company") (NYSE: BRBR) securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON BELLRING BRANDS, INC. (BRBR), CLICK HERE TO PARTICIPATE IN TH...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Gartner, Inc. (“Gartner” or the “Company”) (NYSE: IT) common stock between February 4, 2025 and February 2, 2026, inclusive (the “Class Period”). Gartner investors have until May 18, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GARTNER, INC. (IT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE I...

SINGAPORE & LAS VEGAS--(BUSINESS WIRE)--Horizon Quantum Computing Pte. Ltd. (“Horizon Quantum”), a pioneer of software infrastructure for quantum applications, today announced that it has completed its previously announced business combination (the “Business Combination”) with dMY Squared Technology Group, Inc. (“dMY”) (OTC: “DMYY”, “DMYYU” and “DMYYW”), a publicly traded special purpose acquisition company. The Business Combination was approved by dMY’s shareholders at dMY’s special meeting he...

PARIS--(BUSINESS WIRE)--  Notification and Public Disclosure of transactions by Persons Discharging Managerial Responsibilities TotalEnergies SE has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the UK Market Abuse Regulation. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets ene...

COLUMBUS, Ohio--(BUSINESS WIRE)--Rivera, an independent pharmacy payment integrity company, published a new issue brief examining why the current wave of PBM reform raises the bar for pharmacy benefit oversight without replacing the need for it. Recent federal and state actions have increased scrutiny of how pharmacy benefits are administered, including changes tied to Medicare Part D, ERISA disclosure expectations, and broader oversight of PBM practices. But legislation alone does not verify w...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Alight, Inc. (“Alight” or the “Company”) (NYSE: ALIT) common stock between November 12, 2024 and February 18, 2026, inclusive (the “Class Period”). Alight investors have until May 15, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALIGHT, INC. (ALIT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE...

PARIS--(BUSINESS WIRE)--Availability of the 2025 Universal Registration Document / Annual Financial Report (French version)....

PARIS--(BUSINESS WIRE)--Regulatory News: Veolia Environnement (Paris:VIE) annonce que son document d’enregistrement universel 2025 a été déposé le 19 mars 2026 auprès de l’Autorité des marchés financiers (AMF) sous le numéro D.26-0118. Le document d’enregistrement universel est accessible sur le site internet de la société à l’adresse : https://www.veolia.com/fr/groupe/finance/information-reglementee Des exemplaires du document d’enregistrement universel sont également disponibles au siège admi...

LIMA, Ohio--(BUSINESS WIRE)--Lima, OH is the inaugural city in Fifth Third’s new Small Towns & Small Cities initiative to advance place-based community & economic development....

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...